クロストリジウム診断の世界市場2023年~2027年

■ 英語タイトル:Global Clostridium Diagnostics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR75006-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR75006-23
■ 発行日:2023年2月16日
■ 調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[クロストリジウム診断の世界市場2023年~2027年]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Technavio社の本市場調査レポートでは、世界のクロストリジウム診断市場規模が2022年から2027年の間に2,148.4百万ドルまで到達し、予測期間中に年平均13.69%成長すると推測されています。本レポートではクロストリジウム診断の世界市場を多角的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、技術別(免疫学的検査、分子診断)分析、製品別(クロストリジウム・ディフィシル、ウェルシュ菌、ボツリヌス菌、破傷風菌、その他)分析、エンドユーザー別(病院、 独立研究所、診療所)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、ドイツ、イギリス、中国、カナダ)分析、成長要因・課題・動向、企業状況、企業分析などの内容をまとめています。なお、参入企業情報として、AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析

・世界のクロストリジウム診断市場規模:技術別
- 免疫学的検査技術の市場規模
- 分子診断技術の市場規模

・世界のクロストリジウム診断市場規模:製品別
- クロストリジウム・ディフィシルの市場規模
- ウェルシュ菌の市場規模
- ボツリヌス菌の市場規模
- 破傷風菌の市場規模
- その他製品の市場規模

・世界のクロストリジウム診断市場規模:エンドユーザー別
- 病院における市場規模
- 独立研究所における市場規模
- 診療所における市場規模

・地域別状況
- 北米のクロストリジウム診断市場規模
- ヨーロッパのクロストリジウム診断市場規模
- アジア太平洋のクロストリジウム診断市場規模
- その他地域のクロストリジウム診断市場規模
- アメリカのクロストリジウム診断市場規模
- ドイツのクロストリジウム診断市場規模
- イギリスのクロストリジウム診断市場規模
- 中国のクロストリジウム診断市場規模
- カナダのクロストリジウム診断市場規模


・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要な変数を分析することで、また、複数のソースからのデータを調査・統合・合計することにより、クロストリジウム診断市場の全体像を詳細に提示します。主要産業のインフルエンサーを特定することで、さまざまな市場の側面を提示します。提示されたデータは包括的且つ信憑性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確なクロストリジウム診断市場の成長を予測するための定性的・定量的調査を用い、徹底的な競合状況と詳細に及ぶベンダー選定・分析を提供します。

クロストリジウム診断の世界市場 2023-2027

Technavio社は、クロストリジウム診断市場をモニターしており、2022年から2027年にかけて2,148.4百万ドルの成長が予測され、予測期間中のCAGRは13.69%で加速すると予測しています。当レポートでは、クロストリジウム診断市場の全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。CDIの有病率の増加、高齢化人口の増加、新規治療法の開発などが市場を牽引しています。

テクナビオのクロストリジウム診断市場は以下のように区分されます:

・技術別:
– 免疫測定法
– 分子診断

・製品別:
– クロストリジウム・ディフィシル
– クロストリジウム・パーフリンゲンス
– ボツリヌス菌
– クロストリジウム・テタニ
– クロストリジウム・ソルデリ

・エンドユーザー別:
– 病院
– 独立研究所
– クリニック

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間におけるクロストリジウム診断市場の成長を促進する主な要因の一つとして、新しいワクチンの開発を挙げています。また、ワクチン研究におけるイムノインフォマティクスの利用拡大や、研究開発への高額投資も、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、クロストリジウム診断市場について以下の分野をカバーしています:
– クロストリジウム診断市場のサイジング
– クロストリジウム診断市場予測
– クロストリジウム診断市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc., Novartis AG, Olympus Corp., Pfizer Inc., QIAGEN NV, Siemens AG, Summit Therapeutics Inc., TECHLAB Inc., Thermo Fisher Scientific Inc., and Trinity Biotech Plcなどの企業情報が含まれています。また、クロストリジウム診断市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 08: Executive Summary – Chart on Incremental Growth
o Exhibit 09: Executive Summary – Data Table on Incremental Growth
o Exhibit 10: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 11: Parent market
o Exhibit 12: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 13: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 14: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 15: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global clostridium diagnostics market 2017 – 2021
o Exhibit 19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 – 2021 ($ million)
o 4.2 Technology Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 End user Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – End user Segment 2017 – 2021 ($ million)
o 4.5 Geography Segment Analysis 2017 – 2021
o Exhibit 23: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.6 Country Segment Analysis 2017 – 2021
o Exhibit 24: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 25: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 31: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Technology
o 6.1 Market segments
o Exhibit 32: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 33: Data Table on Technology – Market share 2022-2027 (%)
o 6.2 Comparison by Technology
o Exhibit 34: Chart on Comparison by Technology
o Exhibit 35: Data Table on Comparison by Technology
o 6.3 Immunoassays – Market size and forecast 2022-2027
o Exhibit 36: Chart on Immunoassays – Market size and forecast 2022-2027 ($ million)
o Exhibit 37: Data Table on Immunoassays – Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Chart on Immunoassays – Year-over-year growth 2022-2027 (%)
o Exhibit 39: Data Table on Immunoassays – Year-over-year growth 2022-2027 (%)
o 6.4 Molecular diagnostics – Market size and forecast 2022-2027
o Exhibit 40: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 41: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 42: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 43: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Technology
o Exhibit 44: Market opportunity by Technology ($ million)
o Exhibit 45: Data Table on Market opportunity by Technology ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 46: Chart on Product – Market share 2022-2027 (%)
o Exhibit 47: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 48: Chart on Comparison by Product
o Exhibit 49: Data Table on Comparison by Product
o 7.3 Clostridium difficile – Market size and forecast 2022-2027
o Exhibit 50: Chart on Clostridium difficile – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Clostridium difficile – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Clostridium difficile – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Clostridium difficile – Year-over-year growth 2022-2027 (%)
o 7.4 Clostridium perfringens – Market size and forecast 2022-2027
o Exhibit 54: Chart on Clostridium perfringens – Market size and forecast 2022-2027 ($ million)
o Exhibit 55: Data Table on Clostridium perfringens – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Chart on Clostridium perfringens – Year-over-year growth 2022-2027 (%)
o Exhibit 57: Data Table on Clostridium perfringens – Year-over-year growth 2022-2027 (%)
o 7.5 Clostridium botulinum – Market size and forecast 2022-2027
o Exhibit 58: Chart on Clostridium botulinum – Market size and forecast 2022-2027 ($ million)
o Exhibit 59: Data Table on Clostridium botulinum – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Chart on Clostridium botulinum – Year-over-year growth 2022-2027 (%)
o Exhibit 61: Data Table on Clostridium botulinum – Year-over-year growth 2022-2027 (%)
o 7.6 Clostridium tetani – Market size and forecast 2022-2027
o Exhibit 62: Chart on Clostridium tetani – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Data Table on Clostridium tetani – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Chart on Clostridium tetani – Year-over-year growth 2022-2027 (%)
o Exhibit 65: Data Table on Clostridium tetani – Year-over-year growth 2022-2027 (%)
o 7.7 Clostridium sordellii – Market size and forecast 2022-2027
o Exhibit 66: Chart on Clostridium sordellii – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Data Table on Clostridium sordellii – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Chart on Clostridium sordellii – Year-over-year growth 2022-2027 (%)
o Exhibit 69: Data Table on Clostridium sordellii – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Product
o Exhibit 70: Market opportunity by Product ($ million)
o Exhibit 71: Data Table on Market opportunity by Product ($ million)
• 8 Market Segmentation by End-user
o 8.1 Market segments
o Exhibit 72: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 73: Data Table on End-user – Market share 2022-2027 (%)
o 8.2 Comparison by End-user
o Exhibit 74: Chart on Comparison by End-user
o Exhibit 75: Data Table on Comparison by End-user
o 8.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 76: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 8.4 Independent laboratories – Market size and forecast 2022-2027
o Exhibit 80: Chart on Independent laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Data Table on Independent laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Chart on Independent laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 83: Data Table on Independent laboratories – Year-over-year growth 2022-2027 (%)
o 8.5 Physicians clinics – Market size and forecast 2022-2027
o Exhibit 84: Chart on Physicians clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Data Table on Physicians clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Chart on Physicians clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 87: Data Table on Physicians clinics – Year-over-year growth 2022-2027 (%)
o 8.6 Market opportunity by End-user
o Exhibit 88: Market opportunity by End-user ($ million)
o Exhibit 89: Data Table on Market opportunity by End-user ($ million)
• 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 10 Geographic Landscape
o 10.1 Geographic segmentation
o Exhibit 91: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 10.2 Geographic comparison
o Exhibit 93: Chart on Geographic comparison
o Exhibit 94: Data Table on Geographic comparison
o 10.3 North America – Market size and forecast 2022-2027
o Exhibit 95: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 10.4 Europe – Market size and forecast 2022-2027
o Exhibit 99: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 10.5 Asia – Market size and forecast 2022-2027
o Exhibit 103: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 10.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 107: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 10.7 US – Market size and forecast 2022-2027
o Exhibit 111: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on US – Year-over-year growth 2022-2027 (%)
o 10.8 Germany – Market size and forecast 2022-2027
o Exhibit 115: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 116: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 117: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 10.9 UK – Market size and forecast 2022-2027
o Exhibit 119: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 120: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 121: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 122: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 10.10 China – Market size and forecast 2022-2027
o Exhibit 123: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 124: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 125: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 126: Data Table on China – Year-over-year growth 2022-2027 (%)
o 10.11 Canada – Market size and forecast 2022-2027
o Exhibit 127: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 128: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 129: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 130: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 10.12 Market opportunity By Geographical Landscape
o Exhibit 131: Market opportunity By Geographical Landscape ($ million)
o Exhibit 132: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 11 Drivers, Challenges, and Trends
o 11.1 Market drivers
o 11.2 Market challenges
o 11.3 Impact of drivers and challenges
o Exhibit 133: Impact of drivers and challenges in 2022 and 2027
o 11.4 Market trends
• 12 Vendor Landscape
o 12.1 Overview
o 12.2 Vendor landscape
o Exhibit 134: Overview on Criticality of inputs and Factors of differentiation
o 12.3 Landscape disruption
o Exhibit 135: Overview on factors of disruption
o 12.4 Industry risks
o Exhibit 136: Impact of key risks on business
• 13 Vendor Analysis
o 13.1 Vendors covered
o Exhibit 137: Vendors covered
o 13.2 Market positioning of vendors
o Exhibit 138: Matrix on vendor position and classification
o 13.3 AstraZeneca Plc
o Exhibit 139: AstraZeneca Plc – Overview
o Exhibit 140: AstraZeneca Plc – Product / Service
o Exhibit 141: AstraZeneca Plc – Key news
o Exhibit 142: AstraZeneca Plc – Key offerings
o 13.4 Becton Dickinson and Co.
o Exhibit 143: Becton Dickinson and Co. – Overview
o Exhibit 144: Becton Dickinson and Co. – Business segments
o Exhibit 145: Becton Dickinson and Co. – Key news
o Exhibit 146: Becton Dickinson and Co. – Key offerings
o Exhibit 147: Becton Dickinson and Co. – Segment focus
o 13.5 bioMerieux SA
o Exhibit 148: bioMerieux SA – Overview
o Exhibit 149: bioMerieux SA – Product / Service
o Exhibit 150: bioMerieux SA – Key offerings
o 13.6 DiaSorin SpA
o Exhibit 151: DiaSorin SpA – Overview
o Exhibit 152: DiaSorin SpA – Business segments
o Exhibit 153: DiaSorin SpA – Key news
o Exhibit 154: DiaSorin SpA – Key offerings
o Exhibit 155: DiaSorin SpA – Segment focus
o 13.7 F. Hoffmann La Roche Ltd.
o Exhibit 156: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 157: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 158: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 159: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 160: F. Hoffmann La Roche Ltd. – Segment focus
o 13.8 Ferring BV
o Exhibit 161: Ferring BV – Overview
o Exhibit 162: Ferring BV – Product / Service
o Exhibit 163: Ferring BV – Key offerings
o 13.9 Fujirebio Holdings Inc.
o Exhibit 164: Fujirebio Holdings Inc. – Overview
o Exhibit 165: Fujirebio Holdings Inc. – Product / Service
o Exhibit 166: Fujirebio Holdings Inc. – Key offerings
o 13.10 Hologic Inc.
o Exhibit 167: Hologic Inc. – Overview
o Exhibit 168: Hologic Inc. – Business segments
o Exhibit 169: Hologic Inc. – Key news
o Exhibit 170: Hologic Inc. – Key offerings
o Exhibit 171: Hologic Inc. – Segment focus
o 13.11 Huvepharma
o Exhibit 172: Huvepharma – Overview
o Exhibit 173: Huvepharma – Product / Service
o Exhibit 174: Huvepharma – Key offerings
o 13.12 Novartis AG
o Exhibit 175: Novartis AG – Overview
o Exhibit 176: Novartis AG – Business segments
o Exhibit 177: Novartis AG – Key offerings
o Exhibit 178: Novartis AG – Segment focus
o 13.13 Olympus Corp.
o Exhibit 179: Olympus Corp. – Overview
o Exhibit 180: Olympus Corp. – Business segments
o Exhibit 181: Olympus Corp. – Key news
o Exhibit 182: Olympus Corp. – Key offerings
o Exhibit 183: Olympus Corp. – Segment focus
o 13.14 Pfizer Inc.
o Exhibit 184: Pfizer Inc. – Overview
o Exhibit 185: Pfizer Inc. – Product / Service
o Exhibit 186: Pfizer Inc. – Key news
o Exhibit 187: Pfizer Inc. – Key offerings
o 13.15 QIAGEN NV
o Exhibit 188: QIAGEN NV – Overview
o Exhibit 189: QIAGEN NV – Product / Service
o Exhibit 190: QIAGEN NV – Key news
o Exhibit 191: QIAGEN NV – Key offerings
o 13.16 Siemens AG
o Exhibit 192: Siemens AG – Overview
o Exhibit 193: Siemens AG – Business segments
o Exhibit 194: Siemens AG – Key news
o Exhibit 195: Siemens AG – Key offerings
o Exhibit 196: Siemens AG – Segment focus
o 13.17 Thermo Fisher Scientific Inc.
o Exhibit 197: Thermo Fisher Scientific Inc. – Overview
o Exhibit 198: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 199: Thermo Fisher Scientific Inc. – Key news
o Exhibit 200: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 201: Thermo Fisher Scientific Inc. – Segment focus
• 14 Appendix
o 14.1 Scope of the report
o 14.2 Inclusions and exclusions checklist
o Exhibit 202: Inclusions checklist
o Exhibit 203: Exclusions checklist
o 14.3 Currency conversion rates for US$
o Exhibit 204: Currency conversion rates for US$
o 14.4 Research methodology
o Exhibit 205: Research methodology
o Exhibit 206: Validation techniques employed for market sizing
o Exhibit 207: Information sources
o 14.5 List of abbreviations
o Exhibit 208: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Market Segmentation by End-user
Exhibits8: Executive Summary – Chart on Incremental Growth
Exhibits9: Executive Summary – Data Table on Incremental Growth
Exhibits10: Executive Summary – Chart on Vendor Market Positioning
Exhibits11: Parent market
Exhibits12: Market Characteristics
Exhibits13: Offerings of vendors included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – End user Segment 2017 – 2021 ($ million)
Exhibits23: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits24: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits25: Five forces analysis – Comparison between 2022 and 2027
Exhibits26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits28: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits29: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits30: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits31: Chart on Market condition – Five forces 2022 and 2027
Exhibits32: Chart on Technology – Market share 2022-2027 (%)
Exhibits33: Data Table on Technology – Market share 2022-2027 (%)
Exhibits34: Chart on Comparison by Technology
Exhibits35: Data Table on Comparison by Technology
Exhibits36: Chart on Immunoassays – Market size and forecast 2022-2027 ($ million)
Exhibits37: Data Table on Immunoassays – Market size and forecast 2022-2027 ($ million)
Exhibits38: Chart on Immunoassays – Year-over-year growth 2022-2027 (%)
Exhibits39: Data Table on Immunoassays – Year-over-year growth 2022-2027 (%)
Exhibits40: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits41: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits42: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits43: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits44: Market opportunity by Technology ($ million)
Exhibits45: Data Table on Market opportunity by Technology ($ million)
Exhibits46: Chart on Product – Market share 2022-2027 (%)
Exhibits47: Data Table on Product – Market share 2022-2027 (%)
Exhibits48: Chart on Comparison by Product
Exhibits49: Data Table on Comparison by Product
Exhibits50: Chart on Clostridium difficile – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Clostridium difficile – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Clostridium difficile – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Clostridium difficile – Year-over-year growth 2022-2027 (%)
Exhibits54: Chart on Clostridium perfringens – Market size and forecast 2022-2027 ($ million)
Exhibits55: Data Table on Clostridium perfringens – Market size and forecast 2022-2027 ($ million)
Exhibits56: Chart on Clostridium perfringens – Year-over-year growth 2022-2027 (%)
Exhibits57: Data Table on Clostridium perfringens – Year-over-year growth 2022-2027 (%)
Exhibits58: Chart on Clostridium botulinum – Market size and forecast 2022-2027 ($ million)
Exhibits59: Data Table on Clostridium botulinum – Market size and forecast 2022-2027 ($ million)
Exhibits60: Chart on Clostridium botulinum – Year-over-year growth 2022-2027 (%)
Exhibits61: Data Table on Clostridium botulinum – Year-over-year growth 2022-2027 (%)
Exhibits62: Chart on Clostridium tetani – Market size and forecast 2022-2027 ($ million)
Exhibits63: Data Table on Clostridium tetani – Market size and forecast 2022-2027 ($ million)
Exhibits64: Chart on Clostridium tetani – Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on Clostridium tetani – Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Clostridium sordellii – Market size and forecast 2022-2027 ($ million)
Exhibits67: Data Table on Clostridium sordellii – Market size and forecast 2022-2027 ($ million)
Exhibits68: Chart on Clostridium sordellii – Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Clostridium sordellii – Year-over-year growth 2022-2027 (%)
Exhibits70: Market opportunity by Product ($ million)
Exhibits71: Data Table on Market opportunity by Product ($ million)
Exhibits72: Chart on End-user – Market share 2022-2027 (%)
Exhibits73: Data Table on End-user – Market share 2022-2027 (%)
Exhibits74: Chart on Comparison by End-user
Exhibits75: Data Table on Comparison by End-user
Exhibits76: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits77: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits78: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits80: Chart on Independent laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits81: Data Table on Independent laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits82: Chart on Independent laboratories – Year-over-year growth 2022-2027 (%)
Exhibits83: Data Table on Independent laboratories – Year-over-year growth 2022-2027 (%)
Exhibits84: Chart on Physicians clinics – Market size and forecast 2022-2027 ($ million)
Exhibits85: Data Table on Physicians clinics – Market size and forecast 2022-2027 ($ million)
Exhibits86: Chart on Physicians clinics – Year-over-year growth 2022-2027 (%)
Exhibits87: Data Table on Physicians clinics – Year-over-year growth 2022-2027 (%)
Exhibits88: Market opportunity by End-user ($ million)
Exhibits89: Data Table on Market opportunity by End-user ($ million)
Exhibits90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits91: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits93: Chart on Geographic comparison
Exhibits94: Data Table on Geographic comparison
Exhibits95: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits116: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits117: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits120: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits121: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits123: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits124: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits125: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits126: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits127: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits128: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits129: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits130: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits131: Market opportunity By Geographical Landscape ($ million)
Exhibits132: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits133: Impact of drivers and challenges in 2022 and 2027
Exhibits134: Overview on Criticality of inputs and Factors of differentiation
Exhibits135: Overview on factors of disruption
Exhibits136: Impact of key risks on business
Exhibits137: Vendors covered
Exhibits138: Matrix on vendor position and classification
Exhibits139: AstraZeneca Plc – Overview
Exhibits140: AstraZeneca Plc – Product / Service
Exhibits141: AstraZeneca Plc – Key news
Exhibits142: AstraZeneca Plc – Key offerings
Exhibits143: Becton Dickinson and Co. – Overview
Exhibits144: Becton Dickinson and Co. – Business segments
Exhibits145: Becton Dickinson and Co. – Key news
Exhibits146: Becton Dickinson and Co. – Key offerings
Exhibits147: Becton Dickinson and Co. – Segment focus
Exhibits148: bioMerieux SA – Overview
Exhibits149: bioMerieux SA – Product / Service
Exhibits150: bioMerieux SA – Key offerings
Exhibits151: DiaSorin SpA – Overview
Exhibits152: DiaSorin SpA – Business segments
Exhibits153: DiaSorin SpA – Key news
Exhibits154: DiaSorin SpA – Key offerings
Exhibits155: DiaSorin SpA – Segment focus
Exhibits156: F. Hoffmann La Roche Ltd. – Overview
Exhibits157: F. Hoffmann La Roche Ltd. – Business segments
Exhibits158: F. Hoffmann La Roche Ltd. – Key news
Exhibits159: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits161: Ferring BV – Overview
Exhibits162: Ferring BV – Product / Service
Exhibits163: Ferring BV – Key offerings
Exhibits164: Fujirebio Holdings Inc. – Overview
Exhibits165: Fujirebio Holdings Inc. – Product / Service
Exhibits166: Fujirebio Holdings Inc. – Key offerings
Exhibits167: Hologic Inc. – Overview
Exhibits168: Hologic Inc. – Business segments
Exhibits169: Hologic Inc. – Key news
Exhibits170: Hologic Inc. – Key offerings
Exhibits171: Hologic Inc. – Segment focus
Exhibits172: Huvepharma – Overview
Exhibits173: Huvepharma – Product / Service
Exhibits174: Huvepharma – Key offerings
Exhibits175: Novartis AG – Overview
Exhibits176: Novartis AG – Business segments
Exhibits177: Novartis AG – Key offerings
Exhibits178: Novartis AG – Segment focus
Exhibits179: Olympus Corp. – Overview
Exhibits180: Olympus Corp. – Business segments
Exhibits181: Olympus Corp. – Key news
Exhibits182: Olympus Corp. – Key offerings
Exhibits183: Olympus Corp. – Segment focus
Exhibits184: Pfizer Inc. – Overview
Exhibits185: Pfizer Inc. – Product / Service
Exhibits186: Pfizer Inc. – Key news
Exhibits187: Pfizer Inc. – Key offerings
Exhibits188: QIAGEN NV – Overview
Exhibits189: QIAGEN NV – Product / Service
Exhibits190: QIAGEN NV – Key news
Exhibits191: QIAGEN NV – Key offerings
Exhibits192: Siemens AG – Overview
Exhibits193: Siemens AG – Business segments
Exhibits194: Siemens AG – Key news
Exhibits195: Siemens AG – Key offerings
Exhibits196: Siemens AG – Segment focus
Exhibits197: Thermo Fisher Scientific Inc. – Overview
Exhibits198: Thermo Fisher Scientific Inc. – Business segments
Exhibits199: Thermo Fisher Scientific Inc. – Key news
Exhibits200: Thermo Fisher Scientific Inc. – Key offerings
Exhibits201: Thermo Fisher Scientific Inc. – Segment focus
Exhibits202: Inclusions checklist
Exhibits203: Exclusions checklist
Exhibits204: Currency conversion rates for US$
Exhibits205: Research methodology
Exhibits206: Validation techniques employed for market sizing
Exhibits207: Information sources
Exhibits208: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR75006-23 )"クロストリジウム診断の世界市場2023年~2027年" (英文:Global Clostridium Diagnostics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。